Cargando…
SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line
BACKGROUND: Endometrial cancer (EC) is the most common form of malignant gynecological tumor. Treatment with cisplatin (CDDP) is the mainstay of EC chemotherapy. The apoptotic machinery is regarded as an important etiological factor in chemoresistance. Recent evidence has suggested that overexpressi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826500/ https://www.ncbi.nlm.nih.gov/pubmed/27065754 http://dx.doi.org/10.1186/s12935-016-0304-7 |